Kelly Michael 4
4 · ARS Pharmaceuticals, Inc. · Filed Jun 24, 2024
Insider Transaction Report
Form 4
Kelly Michael
Director
Transactions
- Award
Stock Option (right to buy)
2024-06-20+40,000→ 40,000 totalExercise: $7.73Exp: 2034-06-19→ Common Stock (40,000 underlying)
Footnotes (1)
- [F1]The shares subject to the option will vest in full on the earlier of June 20, 2025 or the date of the Issuer's 2025 annual meeting of stockholders, which date has not been set by the Issuer's Board of Directors.